Their study found that higher serum IL17A levels were significantly associated with more severe DR, with logistic regression analysis confirming a higher risk of both non-proliferative and proliferative diabetic retinopathy in individuals with elevated IL17A levels [68]. The gene discussed is IL17A; the disease is proliferative diabetic retinopathy.